HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neutrogena SPF+100 Claims Spread Too Thin For Ultra Sheer Line – NAD

This article was originally published in The Rose Sheet

Executive Summary

J&J agrees to narrow claims for Neutrogena Ultra Sheer Dry-Touch line to its 100+ product after NAD determines the statements inferred the product's benefits across the entire line.

You may also be interested in...



“Barrier” Sunscreen Claim May Mislead In Certain Contexts – NARB Verdict

Industry self-regulation appellate panel upholds a December 2013 decision from the National Advertising Division recommending that J&J discontinue the “water + sun barrier” claim on labeling for Neutrogena Beach Defense sunscreen products. In other contexts, however, comparing sunscreens to barriers is not likely to mislead consumers, NARB says.

NAD Finds Neutrogena’s Superiority Claims For Helioplex Sunscreens Justified

Neutrogena's "best" and "strongest" and "longest-lasting" claims for it Helioplex-containing sun-care products are adequately substantiated, according to a Sept. 18 report from the National Advertising Division (NAD)

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109158

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel